Patents Assigned to QIAGEN Redwood City, Inc.
  • Patent number: 11043284
    Abstract: The invention provides computer systems and methods for visualization and analysis of relationships between biological data.
    Type: Grant
    Filed: March 11, 2019
    Date of Patent: June 22, 2021
    Assignee: QIAGEN Redwood City, Inc.
    Inventor: Megan E. Laurance
  • Publication number: 20200279618
    Abstract: Disclosed herein are system, method, and computer program product embodiments for aiding in the interpretation of variants observed in clinical sequencing data. An embodiment operates by receiving clinical trial enrollment criteria from a user, including but not limited to genetic targeting criteria; searching a knowledge base of patient test information received from a plurality of independent entities for patients that match the clinical trial enrollment criteria; and providing to the user search results for consented patients that match the clinical trial enrollment criteria.
    Type: Application
    Filed: May 18, 2020
    Publication date: September 3, 2020
    Applicants: QIAGEN Redwood City, Inc., QIAGEN GmbH
    Inventors: Douglas E. BASSETT, JR., Daniel R. Richards, Peer M. Schatz
  • Publication number: 20200279620
    Abstract: Disclosed herein are system, method, and computer program product embodiments for building a community database of allele counts. An embodiment operates by receiving human variant datasets derived from samples generated by distinct users, wherein the users consented to share pooled variant observations with other users; determining that a plurality of variant observations meet the inclusion criteria for a pool; and calculating one or more anonymized allele statistics from the pool.
    Type: Application
    Filed: May 18, 2020
    Publication date: September 3, 2020
    Applicants: QIAGEN Redwood City, Inc, QIAGEN GmbH
    Inventors: Douglas E. Bassett, JR., Daniel R. Richards, Peer M. Schatz
  • Patent number: 10665328
    Abstract: Disclosed herein are system, method, and computer program product embodiments for aiding in the interpretation of variants observed in clinical sequencing data. An embodiment operates by receiving clinical trial enrollment criteria from a user, including but not limited to genetic targeting criteria; searching a knowledge base of patient test information received from a plurality of independent entities for patients that match the clinical trial enrollment criteria; and providing to the user search results for consented patients that match the clinical trial enrollment criteria.
    Type: Grant
    Filed: June 30, 2014
    Date of Patent: May 26, 2020
    Assignees: QIAGEN Redwood City, Inc., QIAGEN GmbH
    Inventors: Douglas E. Bassett, Jr., Daniel R. Richards, Peer M. Schatz
  • Patent number: 10658073
    Abstract: Disclosed herein are system, method, and computer program product embodiments for building a community database of allele counts. An embodiment operates by receiving human variant datasets derived from samples generated by distinct users, wherein the users consented to share pooled variant observations with other users; determining that a plurality of variant observations meet the inclusion criteria for a pool; and calculating one or more anonymized allele statistics from the pool.
    Type: Grant
    Filed: August 15, 2014
    Date of Patent: May 19, 2020
    Assignees: QIAGEN Redwood City, Inc., QIAGEN GmbH
    Inventors: Douglas E. Bassett, Jr., Daniel R. Richards, Peer M. Schatz
  • Patent number: 10453553
    Abstract: Methods for identifying disease-related pathways that can used to identify drug discovery targets, to identify new uses for known drugs, to identify markers for drug response, and related purposes.
    Type: Grant
    Filed: June 10, 2013
    Date of Patent: October 22, 2019
    Assignee: QIAGEN Redwood City, Inc.
    Inventors: Richard O. Chen, Raymond J. Cho, Ramon M. Felciano, Bret Holley, Viresh Patel, Daniel R. Richards, Sushma Selvarajan, Keith Steward, Sara Schneider
  • Publication number: 20190272893
    Abstract: The invention provides computer systems and methods for visualization and analysis of relationships between biological data.
    Type: Application
    Filed: March 11, 2019
    Publication date: September 5, 2019
    Applicant: QIAGEN Redwood City, Inc.
    Inventor: Megan E. LAURANCE
  • Patent number: 10229245
    Abstract: The invention provides computer systems and methods for visualization and analysis of relationships between biological data.
    Type: Grant
    Filed: August 2, 2012
    Date of Patent: March 12, 2019
    Assignee: QIAGEN Redwood City, Inc.
    Inventor: Megan E. Laurance
  • Patent number: 10006148
    Abstract: Methods for identifying disease-related pathways that can be used to identify drug discovery targets, to identify new uses for known drugs, to identify markers for drug response, and related purposes.
    Type: Grant
    Filed: July 28, 2014
    Date of Patent: June 26, 2018
    Assignee: QIAGEN Redwood City, Inc.
    Inventors: Richard O. Chen, Raymond J. Cho, Ramon M. Felciano, Bret Holley, Viresh Patel, Daniel R. Richards, Sushma Selvarajan, Keith Steward, Sara Tanenbaum Schneider
  • Publication number: 20160048564
    Abstract: Disclosed herein are system, method, and computer program product embodiments for building a community database of allele counts. An embodiment operates by receiving human variant datasets derived from samples generated by distinct users, wherein the users consented to share pooled variant observations with other users; determining that a plurality of variant observations meet the inclusion criteria for a pool; and calculating one or more anonymized allele statistics from the pool.
    Type: Application
    Filed: August 15, 2014
    Publication date: February 18, 2016
    Applicants: QIAGEN Redwood City, Inc., QIAGEN GmbH
    Inventors: Douglas E. Bassett, JR., Daniel R. Richards, Peer M. Schatz
  • Publication number: 20150379193
    Abstract: Disclosed herein are system, method, and computer program product embodiments for aiding in the interpretation of variants observed in clinical sequencing data. An embodiment operates by receiving clinical trial enrollment criteria from a user, including but not limited to genetic targeting criteria; searching a knowledge base of patient test information received from a plurality of independent entities for patients that match the clinical trial enrollment criteria; and providing to the user search results for consented patients that match the clinical trial enrollment criteria.
    Type: Application
    Filed: June 30, 2014
    Publication date: December 31, 2015
    Applicants: QIAGEN Redwood City, Inc., QIAGEN GmbH
    Inventors: Douglas E. BASSETT, JR., Daniel R. Richards, Peer M. Schatz